Abstract
A novel benzimidazole series of small-molecule thrombopoietin receptor agonists has been discovered. Herein, we discuss the preliminary exploration of structure–activity relationships within this chemotype.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have